Experimental and clinical data indicate a potential and prolonged neuroprotective role for the metabolite laudanosine against cerebral hypoxia-ischemia in the perinatal period. The clinical relevance is that administration of the neuromuscular blocking drug cisatracurium could be potentially therapeutic for patient and fetus in obstetric anesthesia.
In reply.
FODALE, Vincenzo;MAZZEO, Anna;LUCANTO, Tullio
2005-01-01
Abstract
Experimental and clinical data indicate a potential and prolonged neuroprotective role for the metabolite laudanosine against cerebral hypoxia-ischemia in the perinatal period. The clinical relevance is that administration of the neuromuscular blocking drug cisatracurium could be potentially therapeutic for patient and fetus in obstetric anesthesia.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
